HMR 1402, a novel cardioselective ATP-sensitive potassium channel antagonist, prevents ventricular fibrillation induced by myocardial ischemia

被引：0
|
作者：
Billman, GE
Houle, MS
Englert, HC
Goegelein, H
Busch, AE
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Aventis, Frankfurt, Germany
来源：
CIRCULATION | 2000年 / 102卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1012
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [1] HMR 1402, a novel cardioselective ATP-sensitive potassium channel antagonist, protects against ischaemically-induced ventricular fibrillation
    Billman, GE
    Houle, MS
    Gerlach, U
    Englert, HC
    Goegelein, H
    Busch, A
    EUROPEAN HEART JOURNAL, 2000, 21 : 326 - 326
  • [2] HMR 1883, a novel cardioselective ATP-dependent potassium channel antagonist prevents ventricular fibrillation induced by myocardial ischemia
    Billman, GE
    Englert, HC
    CIRCULATION, 1997, 96 (08) : 2780 - 2780
  • [3] HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel.: Part II:: Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs
    Billman, GE
    Englert, HC
    Schölkens, BA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (03): : 1465 - 1473
  • [4] Influence of a new ATP-sensitive potassium-channel antagonist (HMR 1098) on ventricular fibrillation inducibility during myocardial ischaemia
    Behrens, S
    Zabel, M
    Janssen, A
    Barbierato, M
    Schultheiss, HP
    EUROPEAN HEART JOURNAL, 2001, 22 : 546 - +
  • [5] Low doses of the ATP-sensitive potassium channel antagonist, glibenclamide, protects against ischemia-induced ventricular fibrillation
    Seward, SW
    Billman, GE
    FASEB JOURNAL, 1996, 10 (03): : 182 - 182
  • [6] Effects of a novel cardioselective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido) ethyl]-β-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia:: In vitro and in vivo studies
    Billman, GE
    Houle, MS
    Englert, HC
    Gögelein, H
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01): : 182 - 192
  • [7] CARDIOSELECTIVE ANTIISCHEMIC ATP-SENSITIVE POTASSIUM CHANNEL OPENERS
    ATWAL, KS
    GROVER, GJ
    AHMED, SZ
    FERRARA, FN
    HARPER, TW
    KIM, KS
    SLEPH, PG
    DZWONCZYK, S
    RUSSELL, AD
    MORELAND, S
    MCCULLOUGH, JR
    NORMANDIN, DE
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (24) : 3971 - 3974
  • [8] Effect of the cardioselective ATP-sensitive potassium channel inhibitor HMR 1883 in a porcine model of cardiopulmonary resuscitation
    Krismer, AC
    Wenzel, V
    Voelckel, W
    Witkiewicz, M
    Strohmenger, HU
    Raedler, C
    Lindner, KH
    RESUSCITATION, 2002, 53 (03) : 299 - 306
  • [9] Treatment of myocardial ischemia with ATP-sensitive potassium channel (K-ATP) openers
    Atwal, KS
    Grover, GJ
    CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (05) : 585 - 595
  • [10] HMR 1883, a novel cardioselective inhibitor of the ATP-Sensitive potassium channel.: Part I:: Effects on cardiomyocytes, coronary flow and pancreatic β-cells
    Gögelein, H
    Hartung, J
    Englert, HC
    Schölkens, BA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (03): : 1453 - 1464
12345